Heat Biologics, Inc.
GP96-BASED CANCER THERAPY
Last updated:
Abstract:
The present disclosure relates, inter alia, to compositions and methods for treating cancer, including lung cancer (e.g., Non-Small Cell Lung Cancer), comprising administering (a) a cell harboring an expression vector comprising a nucleotide sequence that encodes a secretable vaccine protein and (b) an immune checkpoint inhibitor to a subject in need thereof.
Status:
Application
Type:
Utility
Filling date:
27 Nov 2018
Issue date:
10 Jun 2021